Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -65,631 | -39,662 | -18,177 | -79,279 | -39,110 |
| Depreciation Amortization | -83 | -300 | -258 | 25,761 | 1,597 |
| Income taxes - deferred | N/A | N/A | N/A | -2,097 | N/A |
| Accounts receivable | -63 | -109 | 38 | 1,049 | 832 |
| Other Working Capital | 994 | -6,296 | -5,383 | 31,814 | 43,193 |
| Other Operating Activity | 6,956 | 4,832 | 2,198 | 4,458 | 1,800 |
| Operating Cash Flow | $-57,827 | $-41,535 | $-21,582 | $-18,294 | $8,312 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 20,449 | 4,426 | -900 | -164,780 | -40,505 |
| PPE Investments | -7,674 | -5,682 | -4,656 | -54,079 | -39,800 |
| Other Investing Activity | -84 | -45 | -9 | -72 | -24 |
| Investing Cash Flow | $12,691 | $-1,301 | $-5,565 | $-218,931 | $-80,329 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 10,357 | 10,131 | 9,986 | 289,433 | 289,076 |
| Other Financing Activity | -39 | -26 | -13 | -48 | -36 |
| Financing Cash Flow | $10,318 | $10,105 | $9,973 | $289,385 | $289,040 |
| Beginning Cash Position | 61,580 | 61,580 | 61,580 | 9,420 | 9,420 |
| End Cash Position | 26,762 | 28,849 | 44,406 | 61,580 | 226,443 |
| Net Cash Flow | $-34,818 | $-32,731 | $-17,174 | $52,160 | $217,023 |
| Free Cash Flow | |||||
| Operating Cash Flow | -57,827 | -41,535 | -21,582 | -18,294 | 8,312 |
| Capital Expenditure | -7,674 | -5,682 | -4,656 | -54,414 | -39,800 |
| Free Cash Flow | -65,501 | -47,217 | -26,238 | -72,708 | -31,488 |